Adenoviral mediated gene transfer
Showing 1 - 25 of >10,000
Melanoma Trial in Boston (Autologous, lethally irradiated melanoma cells)
Active, not recruiting
- Melanoma
- Autologous, lethally irradiated melanoma cells
-
Boston, Massachusetts
- +1 more
Feb 2, 2022
Breast Cancer Trial in Boston (Autologous, Lethally Irradiated Breast Cancer Cells)
Completed
- Breast Cancer
- Autologous, Lethally Irradiated Breast Cancer Cells
-
Boston, Massachusetts
- +1 more
Mar 30, 2022
Breast Cancer Trial in Boston (Autologous, Lethally Irradiated Breast Cancer Cells)
Completed
- Breast Cancer
- Autologous, Lethally Irradiated Breast Cancer Cells
-
Boston, Massachusetts
- +1 more
Mar 30, 2022
Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Renal Cell Carcinoma Trial in Boston (GVAX)
Completed
- Sarcoma, Clear Cell
- +3 more
- GVAX
-
Boston, Massachusetts
- +1 more
Mar 2, 2021
Phenylketonuria Trial in Ankara (SAR444836)
Recruiting
- Phenylketonuria
-
Ankara, TurkeyInvestigational Site Number: 7920001
Aug 7, 2023
Mesothelioma Trial in Philadelphia (SCH 721015)
Completed
- Mesothelioma
- SCH 721015
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Mar 13, 2020
Hereditary Pulmonary Alveolar Proteinosis Trial (Gene-Corrected Macrophages administered by bronchoscopic instillation)
Not yet recruiting
- Hereditary Pulmonary Alveolar Proteinosis
- Gene-Corrected Macrophages administered by bronchoscopic instillation
- (no location specified)
Mar 8, 2023
Wilson Disease Trial in Spain, United States (genetic, other, drug)
Recruiting
- Wilson Disease
- UX701
- +3 more
-
Los Angeles, California
- +11 more
Jul 22, 2022
Glycogen Storage Disease Type IA Trial in Worldwide (genetic, other, drug)
Recruiting
- Glycogen Storage Disease Type IA
- DTX401
- +3 more
-
Orange, California
- +16 more
Jan 13, 2023
Cancer Trial in Philadelphia (recombinant adenovirus-hIFN-beta)
Completed
- Cancer
- recombinant adenovirus-hIFN-beta
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
May 12, 2020
OTC Deficiency Trial in Worldwide (genetic, other, drug)
Recruiting
- OTC Deficiency
- DTX301
- +4 more
-
Aurora, Colorado
- +19 more
Jul 29, 2022
Severe Hemophilia A Subjects Who Received BMN 270 inPrior
Enrolling by invitation
- Hemophilia A
-
London, United KingdomRoyal London Hospital, Barts and the London Hemophilia Center
Mar 13, 2023
Hemophilia A, Gene Therapy, Clotting Disorders Trial in Johannesburg, London, Southampton (Valoctocogene Roxaparvovec)
Recruiting
- Hemophilia A
- +3 more
- Valoctocogene Roxaparvovec
-
Seoul, Korea, Republic of
- +8 more
Jan 6, 2023
Severe Haemophilia A Trial in United Kingdom (valoctocogene roxaparvovec)
Active, not recruiting
- Severe Haemophilia A
- valoctocogene roxaparvovec
-
Basingstoke, United Kingdom
- +5 more
Feb 22, 2022
Hereditary Angioedema, HAE Trial in United States (Dose 1 of BMN 331, Dose 2 of BMN 331, Dose 3 of BMN 331)
Recruiting
- Hereditary Angioedema
- HAE
- Dose 1 of BMN 331
- +4 more
-
Birmingham, Alabama
- +11 more
Jan 26, 2023
Hemophilia A Trial in Worldwide (BAY2599023 (DTX201))
Active, not recruiting
- Hemophilia A
- BAY2599023 (DTX201)
-
Little Rock, Arkansas
- +12 more
Jan 5, 2023
Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and
Recruiting
- Malignant Glioma of Brain
- +8 more
- Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
-
Detroit, MichiganHenry Ford Health System
Jan 9, 2023
Malignant Glioma, Glioblastoma Multiforme Trial in Ann Arbor (Dose Escalation of Ad-hCMV-TK and Ad-hCMV-Flt3L)
Completed
- Malignant Glioma
- Glioblastoma Multiforme
- Dose Escalation of Ad-hCMV-TK and Ad-hCMV-Flt3L
-
Ann Arbor, MichiganUniversity of Michigan Health System Department of Neurosurgery
Aug 25, 2021
Hemophilia A With Inhibitor, Hemophilia A With Anti Factor VIII Trial in United Kingdom, United States (Valoctocogene
Recruiting
- Hemophilia A With Inhibitor
- Hemophilia A With Anti Factor VIII
- Valoctocogene roxaparvovec
-
Los Angeles, California
- +4 more
Aug 2, 2022
Phenylketonuria (PKU) Trial in United Kingdom, United States (BMN 307)
Active, not recruiting
- Phenylketonuria (PKU)
- BMN 307
-
Tampa, Florida
- +3 more
Oct 6, 2021
Liver Biopsy Following Gene Therapy For Hemophilia
Not yet recruiting
- Hemophilia A
- Hemophilia B
- Liver Biopsy
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 27, 2023
Ornithine Transcarbamylase (OTC) Deficiency Trial in Worldwide (scAAV8OTC, Oral prednisone)
Completed
- Ornithine Transcarbamylase (OTC) Deficiency
- scAAV8OTC
- +2 more
-
Aurora, Colorado
- +8 more
Jan 23, 2023
DTX101 (AAVrh10FIX) in Moderate/Severe to Severe Hemophilia B
Completed
- Hemophilia B
-
Little Rock, Arkansas
- +4 more
Jan 4, 2022
Refractory Angina Pectoris, Gene Transfer, Coronary Artery Disease Trial in Copenhagen, Kuopio (AdvVEGF-D, Control Rx)
Recruiting
- Refractory Angina Pectoris
- +2 more
- AdvVEGF-D
- Control Rx
-
Copenhagen, Denmark
- +1 more
Oct 19, 2022